Allplex™ MTB/MDRe Detection is a multiplex real-time PCR assay that detect Mycobacterium tuberculosis (MTB) with Ct value and identify 25 mutations associated with MDR-TB simultaneously. Based on Seegene's proprietary DPO™ and TOCE™ technology, this assay allows providing prompt diagnosis and appropriate treatment guideline for tuberculosis control.
WTC(Wild-type Control) and Internal Control (IC) for assay validity
Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB
Reagent for DNA Detection is provided, purchase of DNA extraction kit is unnecessary
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
Convenient workflow using Seegene’s automated one platform
Automated data interpretation and LIS interlocking with Seegene Viewer
Fast treatment decision by simultaneous screening and detection of antibiotic resistance
Utilization of the UDG system to prevent carry-over contamination
Multiple Ct value in a single channel
The result represents detection of MTB with Isoniazid-Resistance in FAM and CalRed 610 channel. The ct value of MTB is 33.83
 The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.
 Excluded when applied on automation system
 Multi-Drug Resistance
 For use with Seegene NIMBUS & STARlet only